From the Editors
The medical profession as a whole does an exemplary job of training its students in an open, thorough, and energizing manner. More-experienced physicians' willingness to share the latest and most useful information with trainees (and potentially future competitors) has continued throughout the history of medical education with remarkably few exceptions.
The quirky story of the obstetric forceps that were kept secret for more than 100 years by 5 generations of the Chamberlen family must be the extreme outlier, and the rarity of such a story in medicine contrasts sharply with the widespread reliance on secrets in much of the corporate world. Alongside physicians' dedication to the alleviation of suffering, generosity in teaching is one of the noblest aspects of our profession.
This issue of the Journal of VitreoRetinal Diseases (JVRD) continues that trend with a special collection of articles by talented young investigators. They have been carefully selected and curated by our 3 exceptional JVRD deputy editors-Drs Szilárd Kiss, Mario R. Romano, and Yoshihiro Yonekawawho, with this issue's authors, embody and exemplify the bright future of our vitreoretinal specialty.
Donald J. D'Amico, MD
Editor-in-Chief
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Innovation is seeing what everyone has seen and thinking what nobody else has thought.
-Albert Szent-Györgyi, Nobel Prizewinning Hungarian biochemist
It is with great pleasure that we, the deputy editors, under the leadership and guidance of Editor-in-Chief Donald J. D'Amico, MD, present this issue of JVRD featuring original and insightful work by the next generation of retina specialists. Although the 3 of us, Mario, Yoshi, and I, still count ourselves among the group of young investigators, we were tasked with assembling manuscripts that highlight the talents of those upand-comers who are already shaping and will continue to shape our field. In the 2019 American Society of Retina Specialists (ASRS) Preferences and Trends Membership Survey, more than half of US and international respondents indicated that they have been in practice for less than 15 years; in the United States, nearly one-third of respondents finished fellowship less than 8 years prior. It is this group of young colleagues, as well as fellows in training, that we wished to feature in this issue of JVRD.
In an era in which seemingly every headline highlights the challenges faced by physicians in the current health care environment, it's reassuring and inspiring to know that the rising leaders in our field continue to push forward our understanding of retinal disorders and treatment paradigms. Despite these everyday struggles, we should remember that society has bestowed on us the privilege of caring for those who are sick; in return, it is our responsibility to ensure that we take the most scientific, socioeconomically sound, and holistic approach.
Only through scientific inquiry are these obligations truly fulfilled.
As this issue came together, I was struck by 3 things: first was the overwhelming response to our request for manuscripts for this special issue; second was the diverse group of young investigators eager to share their work; and third was the continued interest in addressing medical and surgical research questions.
During my training, perhaps the greatest innovation for retina patients was the introduction of antivascular endothelial growth factor (anti-VEGF) therapy for the treatment of exudative age-related macular degeneration (and along with this, the overwhelming use of intravitreal injections as a treatment paradigm). For this current crop of young investigators, applying the same intravitreal anti-VEGF therapies to the treatment of diabetic eye disease may represent their greatest paradigm shift. As the 2019 PAT Survey highlights, anti-VEGF therapy is now the first line of treatment in most cases of diabetic macular edema (DME); the use of focal laser for DME continues to decline. However, there is still much debate on the exact role of intravitreal pharmacotherapy for proliferative and nonproliferative retinopathy. Several articles in this issue, especially Dr Rishi P. Singh's ASRS Presidents' Young Investigator Award Lecture, address this revolution and continued controversy in our approach to diabetic retinopathy treatment.
No introduction to the JVRD Retina Young Investigators issue would be complete without a wholehearted thank you to all the mentors who have helped shape these young minds, for as Sir Isaac Newton is credited with saying, 'If I have seen further than others, it is by standing upon the shoulders of giants.'
Welcome to the Retina Young Investigators issue. In this special issue, we feature several manuscripts that teach us about macular hole (MH). The International Vitreomacular Traction Study Group published in 2013 an optical coherence tomography (OCT)-based anatomic classification system on vitreomacular adhesion, traction, and MHs. The classification was mainly related to the changes on the retinal surface in terms of vitreous attachment being focal or broad (more or less than 1500 microns) and the size of the MH (more or less than 250 to 400 microns).
New evidence supports the hypothesis that pathologies of the vitreoretinal interface are responsible not only for epiretinal, but also for intraretinal changes, and that the key role of such changes is played by the retinal macroglia-the Müller cells. Therefore, decreased visual function can be the result of the combination of physical traction and Müller cell-induced proliferation. The activation of Müller cells, with reactive gliosis, is characterized by hypertrophy, proliferation, and upregulation of glial fibrillary acidic protein (GFAP). The tangential centripetal traction and the overexpression of GFAP may cause intraretinal changes, such as outer and inner neuronal damage. The combination of intraretinal gliosis and physical traction can result in the formation of the continuous ectopic inner foveal layers recently described on OCT as an intraretinal uninterrupted band from inner retinal layers across the fovea.
The stronger adhesion between Müller cells and the inner limiting membrane (ILM) proportionally increases the risk of morphological damage after peeling, with the amount of retinal tissue removed by the macular peeling being directly correlated to the level of GFAP in the excised specimen. Moreover, because Mü ller cells also play an important role in the maintenance of the inner bloodretinal barrier, their damage can contribute to increase vascular permeability.
The Müller cells can also play an important role in the closure of large MHs. Histopathological studies have shown that Müller cell-induced gliosis is an essential factor for MH healing; therefore, to close large MHs, we are looking for more gliosis. The gliosis is modulated by neurotrophic factors and basic fibroblast growth factor present on the ILM and on the platelet-rich plasma (PRP). The invertedflap technique and PRP application are thus mechanistically attractive options for large MHs. Nevertheless, the main concern about using an ILM flap is that it might create a larger defect in the ellipsoid zone and the external limiting membrane than in cases without an inverted flap. The reason seems to be related to the sealing with glial proliferation and to potential Müller glial-mesenchymal transition with releases of extracellular and therefore intraretinal fibrosis.
Szilárd Kiss, MD
In this JVRD issue, Khanani and colleagues compare the visual outcomes of patients with MH or vitreomacular traction who underwent vitrectomy in one eye and ocriplasmin injection in the other eye. Cunningham and colleagues report a series of a relatively rare MH presentation: hole formation after vitrectomy for retinal detachment repair. Both papers advance our understanding of MH treatment and pathogenesis. MH surgery is one of the most common procedures that we perform as retina specialists, but there is plenty of room to further improve outcomes.
Welcome to JVRD's Retina Young Investigators issue. This special edition is devoted to featuring manuscripts authored by early-career retina specialists. The young investigators are all first or senior authors who examined stimulating clinical questions. The ASRS also has a strong focus on cultivating young members, directly seen in its dedication to the Early Career Section, Fellows-in-Training Section, Fellowship Directors Section, and recognition for mentorship. A vital component of ASRS and JVRD's mission is to engage, develop, and learn from the next generation of retina specialists.
My main personal motivation for pursuing research is not for the purpose of publishing in and of itself-rather, it's the joy that comes with tackling questions that I feel passionate about with colleagues and trainees who share the same curiosity, in the hope of ultimately making a contribution to improve patient care. I'm certain this sentiment is shared by many of the authors in this issue.
However, the scientific process is by no means an easy feat. For every paper, we formulate a thought-provoking hypothesis, carefully design the study, meticulously collect data, diligently analyze and interpret the results, and go through multiple drafts of the manuscript and hopefully survive the peer-review process to come out with a stronger, publishable product. We have a sentimental attachment to each of our studies, partly because of this rigorous, yet fulfilling, process. Having a dedicated platform such as this JVRD issue to collectively present the fruit of such efforts is a testament to the value of the work of young investigators and our mentors.
Two recurring themes in this special issue highlight the interests of the JVRD/ASRS young investigators: OCT angiography (OCTA) and vitreoretinal surgery. Carolina Francisconi, MD, employs OCTA to examine the foveal avascular zone after pneumatic retinopexy; Chirag Shah, MD, MPH, identifies subclinical foveal vascular changes in patients with systemic lupus erythematosus; and Verena R. Juncal, MD, assesses the effects of projection artifact removal, an ongoing clinical need to optimize OCTA imaging. On the surgical front, Elizabeth A. Atchison, MD, presents the possibility of eliminating topical steroids after vitrectomy, Dr Gerardo González-Saldivar's simulated surgical skills study compares camera aperture settings for 3-dimensional surgery, and Dr Rajeev H. Muni's team provides an insightful editorial on retinal detachment surgery focused around the PIVOT trial. Lastly, we can't complete a discussion of young investigators' interests without highlighting Dr Michael J. Venincasa's analysis of Dr Jay Sridhar's popular retina podcast as an emerging method of medical education.
The deputy editor team thanks JVRD, ASRS, our inspirational Editor-in-Chief, Donald J. D'Amico, MD, and the many talented contributors to this innovative project. Our hope is that this special issue encourages even more young investigators to pursue scientific inquiry as part of their careers to continue advancing our field, one paper at a time. 
